Humans survived with titanium hearts in 100 days – the first
Titanium hearts can serve as a stopgap, for people with your heart failure, waiting for a donor organ
Bivacor is a complete replacement of the heart made by titanium.
Jason Fochtman / Houston Chronicle via Getty Images
An Australian fifty man has become the first person in the world with an artificial heart made in hospital titanium. The phone is used as a stop for people with heart failure that are waiting for a heart, while the previous recipients of this artificial heart were in the US hospitals.
The man has been with the device for more than three months, operated to receive a prosperous human heart. The man is recovering well, according to Sydney Sandney’s Hospital, Australian, the sixth person worldwide is the device to receive the device, but is known as Bibacor for more than a month.
“That’s definitely important development in the field,” says Julian Smith, the Cardiac Surgeon of Melbourne at the Victorian Heart Institute of Melounce University Melbourne, Australia.
To help Science Journalism
If you enjoy this article, consider entering award-winning journalism Subscribe. By purchasing subscription, you are helping to ensure the future of stories about the discoveries and ideas that are conformed to today.
“It’s very innovative,” Sarah Aitken says, a vascular surgeon at the University of Sydney, but it still adds many questions about unanswered function and the last cost of the device. “This type of research is very difficult to do because it is very expensive” and has very high risk involved, says Aitken.
The final success will help people understand how to deal with this device in the real world, says Joseph Rogers, president of the heart cardiologist cardiologist and the Texas Heart Institute in Houston. “They were not constantly monitored by doctors,” says Rogers, who did the first test in the United States last year.
In all cases, Bivacor was used as a temporary measure before making the donor available to the heart. Some cardiologists say that it may be a permanent option for people who do not have the right to transplants, for age or other health conditions, even if the idea must be tested. In the United States, 7 million adults live next to heart failure, but about 4,500 heart transplants were made in 2023, partly due to a donor deficiency.
Hanging rotor
Bivacor Daniel Timms invented by biomedical engineers, created a company that had the name of the device, on Huntington beach, California and Southport, Australia.
The device is replacing a complete heart and works as a constant pump. The magnetic rotor suspended blood promotes in common pulsations throughout the body. The cable under the skin connects a tunnel to a portable external driver that controls your device during the day and can be accessed online at night.
Many mechanical heart devices maintain the left side of the heart, and usually collects blood in the pool, pumping blood 35 million times a year. But these devices have many parts and often have failures. Bivacor has only a moving, according to the theory, has been less of mechanical wear problems, says Rogers.
US tests
Bibacor’s Australian receptor had severe heart failure and received a titanium device in six-hour operation in November. In February, he discharged from the hospital, stayed at a residence and had a relatively normal life. In March, he received the donor’s heart.
In the US trial directed by Rogers, five men in the mid-decade of the fifties received the first version of the Bivacor device last year. The device lasted the hospital every month, but was not designed to help at home. Five individuals later discharged donor hearts. Rogers plans to present results in the April scientific meeting.
Since then, the Vivacor team has improved the risk of reducing the risk of failure.
The US Food and Drug Administration (FDA) has approved expansion of another 15 particles. Aitken says there are many steps, “before it became a kind of treatment for the general public.”
In February, the FDA also accepted the first test PIG-Organ TransplantsOther competitors technology to help deal with the global lack of donor organs.
This article reproduces with permission and has been First posted March 13, 2025.
